Registry of Lobbyists
MS Canada / SP Canada
Subject matters | Details | Categories |
---|---|---|
Budget, Health, Research and Development, Taxation and Finance
|
Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
|
Policies or Program
|
Budget, Health, Research and Development, Taxation and Finance
|
Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities
|
Legislative Proposal, Bill or Resolution
|
Budget, Employment and Training, Health, Taxation and Finance
|
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
|
Regulation
|
Budget, Health, Housing, Taxation and Finance
|
Canada Health Act and regulations, as it relates to long-term and home care
|
Regulation
|
Budget, Health, Taxation and Finance
|
Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care
|
Policies or Program
|
Budget, Employment and Training, Health, Pensions, Taxation and Finance
|
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities
|
Policies or Program
|
Budget, Health, Research and Development, Science and Technology, Taxation and Finance
|
CIHR as it relates to federal funding & long term investment in health research
|
Policies or Program
|
Budget, Employment and Training, Health, Housing, Pensions, Taxation and Finance
|
Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities
|
Policies or Program
|
Budget, Health, Taxation and Finance
|
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
|
Policies or Program, Legislative Proposal, Bill or Resolution, Regulation
|
Budget, Employment and Training, Health, Taxation and Finance
|
Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities
|
Regulation, Policies or Program
|
Budget, Health, Research and Development, Science and Technology
|
Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions.
|
Policies or Program, Legislative Proposal, Bill or Resolution
|
Budget, Employment and Training, Health, Housing, Labour, Pensions, Research and Development, Science and Technology, Taxation and Finance, Transportation
|
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
|
Regulation, Legislative Proposal, Bill or Resolution, Policies or Program
|
Budget, Health, Housing, Taxation and Finance
|
Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers
|
Policies or Program
|
Budget, Taxation and Finance
|
Measures and funding for the charitable sector generally
|
Policies or Program
|
Budget, Health, Housing, Taxation and Finance
|
National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities
|
Policies or Program
|
Budget, Health, Housing, Taxation and Finance
|
Safe Long-Term Care Act with respect to persons affected by MS
|
Legislative Proposal, Bill or Resolution
|
Budget, Health, Research and Development, Science and Technology, Taxation and Finance
|
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|